Transforming growth factor beta signaling pathway, SMAD-dependent (TGF-β/SMAD pathway)

The **transforming growth factor beta/SMAD pathway** refers to a highly conserved, canonical cellular signaling mechanism initiated by transforming growth factor beta (TGF-β) ligands binding to their type II and type I serine/threonine kinase receptors[1][2][6]. Upon ligand binding, these receptors phosphorylate intracellular SMAD transcription factors (especially SMAD2/3), which then form complexes with co-SMAD (SMAD4) and translocate into the nucleus to regulate gene expression[2][3][5]. This pathway orchestrates diverse biological processes including cell cycle arrest, differentiation, apoptosis, migration, immune regulation, and embryonic development[1][2][3][5][6]. Dysregulation of the TGF-β/SMAD pathway has pathogenic roles in cancer, fibrosis, cardiovascular and immune diseases, and is an active area of therapeutic development[4][5][7]. Notably, the term "TGF-β/SMAD pathway" denotes the entire signal transduction system—rather than a single, druggable target molecule or receptor—spanning extracellular ligand, membrane receptors, and intracellular effectors[2][4][6]. Clarification: - The **TGF-β/SMAD pathway** is not a single molecule or receptor, but a multicomponent signaling pathway. - If a specific molecule (e.g., "TGF-β receptor type I," "SMAD2," or "SMAD4") is the target of interest, structured information can be provided for that discrete molecular entity. - As written, this entry is too broad to define a canonical drug target; the major components (e.g., TGF-β1, TGFBR1, SMAD2) are each considered valid therapeutic targets individually[1][2][6].

Other names

TGF-β signaling pathwayTGF-β/SMAD pathwayTransforming growth factor beta (TGFβ) pathwayCanonical TGF-β pathwaySmad-mediated TGF-β signaling

Inhibition of ligand–receptor binding (antibodies or ligand traps) Inhibition of receptor kinase activity (small-molecule inhibitors) Blockade of SMAD nuclear translocation or DNA binding Downstream modulation of gene transcription